<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-84AVA7GG</identifier><date>2013</date><creator>Mencinger, Marina</creator><relation>documents/doc/8/URN_NBN_SI_doc-84AVA7GG_001.pdf</relation><relation>documents/doc/8/URN_NBN_SI_doc-84AVA7GG_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 94-104</format><identifier identifier_type="COBISSID_HOST">1536379</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-84AVA7GG</identifier><language>slv</language><publisher>Kancerološko združenje Slovenskega zdravniškega društva</publisher><publisher>Onkološki inštitut</publisher><source>Onkološki vikend</source><rights>BY-NC-ND</rights><subject language_type_id="eng">cisplatin</subject><subject language_type_id="slv">kemoterapija</subject><subject language_type_id="slv">napredovali rak</subject><subject language_type_id="slv">rak sečnega mehurja</subject><title>Izzivi v obravnavi napredovalega raka sečnega mehurja</title></Record>